An analysis of the effect of routine medications on hemodialysis vascular access survival [17]

Nephron

Volumn 78, Issue 3, 1998, Pages 365-368

  Diskin, C J ^a   Stokes, T J ^a   Thomas, S G ^a   Ravis, W ^a   Lock, S ^a   Thomas, J ^a   Panus, L W ^a   Dansby, L ^a   Carter, T ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HEPARIN; INSULIN; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; ORAL ANTIDIABETIC AGENT; PENTOXIFYLLINE; WARFARIN;

HEMODIALYSIS; HUMAN; LETTER; MORBIDITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOSIS; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; HUMANS; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; THROMBOSIS;

EID: 0031939451     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000044961     Document Type: Letter

References (10)